Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Suboptimal Beta-Lactam Therapy in Critically Ill Children: Risk Factors and Outcome.
Van Der Heggen T, Dhont E, Willems J, Herck I, Delanghe JR, Stove V, Verstraete AG, Vanhaesebrouck S, De Paepe P, De Cock PAJG. Van Der Heggen T, et al. Among authors: de cock pajg. Pediatr Crit Care Med. 2022 Jul 1;23(7):e309-e318. doi: 10.1097/PCC.0000000000002951. Epub 2022 Apr 15. Pediatr Crit Care Med. 2022. PMID: 35426861 Clinical Trial.
Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass to optimize dosing regimens for children undergoing cardiac surgery.
De Cock PA, Mulla H, Desmet S, De Somer F, McWhinney BC, Ungerer JP, Moerman A, Commeyne S, Vande Walle J, Francois K, Van Hasselt JG, De Paepe P. De Cock PA, et al. J Antimicrob Chemother. 2017 Mar 1;72(3):791-800. doi: 10.1093/jac/dkw496. J Antimicrob Chemother. 2017. PMID: 27999040 Clinical Trial.
Dose optimization of piperacillin/tazobactam in critically ill children.
De Cock PAJG, van Dijkman SC, de Jaeger A, Willems J, Carlier M, Verstraete AG, Delanghe JR, Robays H, Vande Walle J, Della Pasqua OE, De Paepe P. De Cock PAJG, et al. J Antimicrob Chemother. 2017 Jul 1;72(7):2002-2011. doi: 10.1093/jac/dkx093. J Antimicrob Chemother. 2017. PMID: 28387840
51 results